Testosterone replacement therapy (TRT) can change your cholesterol panel, but the effect is usually modest and varies by person. The most consistent finding is a small drop in HDL (“good”) cholesterol, while LDL and triglycerides may stay flat, fall slightly, or occasionally rise. Because of this, clinicians typically check a lipid panel before starting TRT and again during follow-up.
This guide explains what the numbers mean, why TRT can shift them, and how to read your results alongside other TRT labs.
Does TRT raise or lower cholesterol?
Published meta-analyses of testosterone therapy in men suggest small average reductions in total cholesterol and HDL, with inconsistent changes in LDL and triglycerides. Results differ by formulation, dose, baseline health, and study length, so individual response is hard to predict. Low testosterone itself is also associated with an unfavorable lipid and metabolic profile in many men, so treatment can move some markers in a helpful direction while lowering HDL.
Why TRT can lower HDL
Testosterone appears to increase activity of hepatic lipase, an enzyme that helps clear HDL particles. Higher androgen exposure can therefore reduce circulating HDL. Oral, chemically modified androgens are generally associated with larger HDL reductions than injectable testosterone cypionate, which is one reason injectables are the standard option in clinical practice.
Which lipid numbers should you track on TRT?
A standard fasting or non-fasting lipid panel covers the key markers. Ask your clinician to review all of them together rather than focusing on one value.
Total cholesterol, LDL and HDL
LDL is the main target for cardiovascular risk management. HDL matters less on its own than it once did, because raising or lowering HDL has not reliably changed outcomes in trials. A modest HDL decline on TRT is therefore interpreted in context, not in isolation.
Triglycerides and non-HDL cholesterol
Triglycerides respond strongly to body weight, alcohol, sugar intake, and sleep. Non-HDL cholesterol (total minus HDL) captures all atherogenic particles and is often a more useful number than HDL alone. ApoB, where available, offers an even more direct count of atherogenic particles.
How does this fit with TRT cardiovascular safety?
Lipids are one piece of cardiovascular risk. The large TRAVERSE trial, which followed middle-aged and older men with low testosterone and elevated cardiovascular risk, found testosterone therapy was non-inferior to placebo for major adverse cardiac events. That does not remove the need for monitoring. For a broader view, see our review of TRT cardiovascular health and what the evidence says.
Other labs often move alongside lipids and deserve the same attention, particularly hematocrit on TRT and estradiol levels on TRT.
What else can make your lipid panel look different on TRT?
Several non-TRT factors can shift results between tests. Fasting status affects triglycerides, a recent illness or intense training block can temporarily change values, and changes in body weight often matter more than the testosterone itself. Starting a GLP-1 medication, for example, commonly improves triglycerides and LDL as weight falls, which can mask or offset TRT effects.
For consistency, many clinicians suggest drawing labs at the same time of day, under similar fasting conditions, and at a similar point in the injection cycle. Shift workers with irregular sleep and meal timing may see more test-to-test variability, so comparing trends across several panels is more informative than reacting to a single result.
When should you test, and what can you do?
A reasonable pattern, which your clinician may adjust, is a baseline lipid panel before starting, a recheck at roughly three to six months, and then at least annually if results are stable. Test sooner if you change dose, formulation, or medications.
Lifestyle factors usually have a larger effect on lipids than TRT does. Some options clinicians commonly discuss include:
- Regular aerobic and resistance training, which can raise HDL and lower triglycerides
- Limiting alcohol, refined carbohydrates, and ultra-processed food
- Prioritizing sleep, which is often disrupted for shift workers
- Discussing statins or other lipid-lowering therapy if LDL or ApoB stays elevated
Never stop or change prescribed medication without talking to your clinician. Individual targets depend on your overall risk, family history, and other conditions.
Frequently asked questions
Does testosterone cypionate raise LDL cholesterol?
Not consistently. Studies show small, variable LDL changes on injectable testosterone, and many men see little change. Your own panel is the best guide.
Is a lower HDL on TRT dangerous?
A modest HDL decrease is common and is generally judged alongside LDL, ApoB, blood pressure, glucose, and overall risk rather than treated as a standalone problem.
How often should I check cholesterol on TRT?
Commonly at baseline, within the first three to six months, and then yearly if stable, though your clinician may recommend a different schedule.
Ready to start or review your hormone plan? Explore RespondWell treatments and work with a licensed clinician who monitors your labs, including lipids, throughout therapy.